{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T22:00:10Z","timestamp":1768773610419,"version":"3.49.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1097\/00000441-200512000-00012","type":"journal-article","created":{"date-parts":[[2005,12,9]],"date-time":"2005-12-09T09:04:51Z","timestamp":1134119091000},"page":"336-342","source":"Crossref","is-referenced-by-count":36,"title":["Polycystic Ovarian Syndrome and the Metabolic Syndrome"],"prefix":"10.1016","volume":"330","author":[{"given":"Belinda M.","family":"Sartor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard P.","family":"Dickey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/00000441-200512000-00012_bb0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","article-title":"Amenorrhea associated with bilateral polycystic ovaries","volume":"29","author":"Stein","year":"1935","journal-title":"Am J Obstet Gynecol"},{"key":"10.1097\/00000441-200512000-00012_bb0010","series-title":"Polycystic ovary syndrome","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","author":"Zawadski","year":"1992"},{"key":"10.1097\/00000441-200512000-00012_bb0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"The Rotterdam ESHRE\/ASRM-sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1097\/00000441-200512000-00012_bb0020","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0002-9343(01)00979-2","article-title":"Polycyastic ovaries in hirsute women with normal menses","volume":"111","author":"Carmina","year":"2001","journal-title":"Am J Med"},{"key":"10.1097\/00000441-200512000-00012_bb0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2265.1992.tb02296.x","article-title":"How common are polycystic ovaries in normal women and what is their significance for the fertility of the population","volume":"37","author":"Clayton","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1097\/00000441-200512000-00012_bb0030","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0140-6736(88)91612-1","article-title":"Polycystic ovaries: a common finding in normal women","volume":"1","author":"Polson","year":"1988","journal-title":"Lancet"},{"key":"10.1097\/00000441-200512000-00012_bb0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1479-828X.1994.tb01041.x","article-title":"The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women","volume":"34","author":"Farquhar","year":"1994","journal-title":"Aust NZ Obstet Gynaecol"},{"key":"10.1097\/00000441-200512000-00012_bb0040","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/humrep\/12.5.905","article-title":"Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound","volume":"12","author":"Carmina","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1097\/00000441-200512000-00012_bb0045","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1210\/jc.2003-031600","article-title":"Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome","volume":"89","author":"Adams","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200512000-00012_bb0050","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200512000-00012_bb0055","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200512000-00012_bb0060","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1093\/humrep\/deg440","article-title":"Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet","volume":"18","author":"Carmina","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1097\/00000441-200512000-00012_bb0065","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200512000-00012_bb0070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1097\/00000441-200512000-00012_bb0075","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2337\/diacare.24.6.1050","article-title":"Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes","volume":"24","author":"Peppard","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1097\/00000441-200512000-00012_bb0080","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0015-0282(16)54892-4","article-title":"Women with polycystic ovary syndrome wedge resected in 1956 to 1975: a long-term follow-up focusing on natural history and circulating hormones","volume":"57","author":"Dahlgren","year":"1992","journal-title":"Fertil Steril"},{"key":"10.1097\/00000441-200512000-00012_bb0085","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/01.ATV.15.7.821","article-title":"Coronary heart disease risk factors in women with polycystic ovary syndrome","volume":"15","author":"Talbott","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1097\/00000441-200512000-00012_bb0090","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/humrep\/16.3.556","article-title":"Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population","volume":"16","author":"Elting","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1097\/00000441-200512000-00012_bb0095","first-page":"403","article-title":"Chronic anolvulation syndrome and associated neoplasia","volume":"61","author":"Coulam","year":"1983","journal-title":"Obstet Gynecol"},{"key":"10.1097\/00000441-200512000-00012_bb0100","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2003.08.002","article-title":"Polycystic ovary syndrome: syndrome XX?","volume":"14","author":"Sam","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"10.1097\/00000441-200512000-00012_bb0105","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0026-0495(03)00104-5","article-title":"Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome","volume":"52","author":"Glueck","year":"2003","journal-title":"Metabolism"},{"key":"10.1097\/00000441-200512000-00012_bb0110","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"Apridonidze","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200512000-00012_bb0115","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogensis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1097\/00000441-200512000-00012_bb0120","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1210\/jc.2002-020363","article-title":"Decreased insulin receptor (IR) autophosphorylation in fibroblasts in patients with PCOS: effects of serine kinase inhibitors and IR activators","volume":"87","author":"Li","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200512000-00012_bb0125","first-page":"3110","article-title":"Selective insulin resistance in the polycystic overy syndrome","volume":"84","author":"Book","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200512000-00012_bb0130","doi-asserted-by":"crossref","first-page":"E1047","DOI":"10.1152\/ajpendo.00361.2004","article-title":"Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling","volume":"288","author":"Corbould","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1097\/00000441-200512000-00012_bb0135","first-page":"1147","article-title":"Impaired adipocyte lipolysis in nonobese women with the polycystic ovary syndrome: a possible link to insulin resistance?","volume":"82","author":"Ek","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200512000-00012_bb0140","first-page":"E197","article-title":"Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes","volume":"264","author":"Rosenbaum","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1097\/00000441-200512000-00012_bb0145","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2337\/diabetes.49.6.883","article-title":"The perils of portliness: causes and consequences of visceral adiposity","volume":"49","author":"Montague","year":"2000","journal-title":"Diabetes"},{"key":"10.1097\/00000441-200512000-00012_bb0150","first-page":"2854","article-title":"Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features","volume":"81","author":"Morales","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200512000-00012_bb0155","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1210\/jcem-66-1-165","article-title":"Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization","volume":"66","author":"Waldstreicher","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200512000-00012_bb0160","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1210\/jcem-73-4-811","article-title":"Serum bioactive and immunoreactive LH and FSH levels in women with cycle abnormalities, with or without PCOD","volume":"73","author":"Fauser","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200512000-00012_bb0165","first-page":"2248","article-title":"Determinants of abnormal gonadotropin secretion in clnically defined women with PCOS","volume":"82","author":"Taylor","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200512000-00012_bb0170","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0889-8529(05)70071-2","article-title":"Neuroendocrine aspects of polycystic ovary syndrome","volume":"28","author":"Marshall","year":"1999","journal-title":"Endocrinol Metab Cln North Am"},{"key":"10.1097\/00000441-200512000-00012_bb0175","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/mend.13.6.0311","article-title":"Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries","volume":"13","author":"Nelson","year":"1999","journal-title":"Mol Endocrinol"},{"key":"10.1097\/00000441-200512000-00012_bb0180","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1210\/jcem.86.12.8088","article-title":"The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome","volume":"86","author":"Nelson","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200512000-00012_bb0185","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0889-8529(05)70070-0","article-title":"Ovarian and adrenal function in polycystic ovary syndrome","volume":"28","author":"Rosenfield","year":"1999","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1097\/00000441-200512000-00012_bb0190","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound periphaeral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"10.1097\/00000441-200512000-00012_bb0195","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1210\/jcem-57-2-356","article-title":"Insulin resistance in nonobese patients with polycystic ovarian disease","volume":"57","author":"Chang","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200512000-00012_bb0200","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"10.1097\/00000441-200512000-00012_bb0205","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1097\/00000441-200512000-00012_bb0210","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1210\/endo-123-2-733","article-title":"Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells","volume":"123","author":"Cara","year":"1988","journal-title":"Endocrinology"},{"key":"10.1097\/00000441-200512000-00012_bb0215","first-page":"2001","article-title":"Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system","volume":"83","author":"Nestler","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200512000-00012_bb0220","first-page":"881","article-title":"Insulin infusion amplifies 17-\u03b1-hydroxy-corticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity","volume":"81","author":"Moghetti","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200512000-00012_bb0225","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJM199608293350902","article-title":"Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome","volume":"335","author":"Nestler","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1097\/00000441-200512000-00012_bb0230","first-page":"556","article-title":"17 Alpha-hydroxyprogester-one responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome after dietary weighat loss","volume":"82","author":"Jakubowicz","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200512000-00012_bb0235","first-page":"51","article-title":"Le virilisme pilaire et son association a l'insuffisance glylotytique (diabetes des femmes a barbe)","volume":"8a6","author":"Achard","year":"1921","journal-title":"Ball Acad Nat Med (Paris)"},{"key":"10.1097\/00000441-200512000-00012_bb0240","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","article-title":"Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome","volume":"36","author":"Kiddy","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1097\/00000441-200512000-00012_bb0245","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1210\/jcem-68-1-173","article-title":"Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss","volume":"68","author":"Pasquali","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200512000-00012_bb0250","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1056\/NEJM199806253382603","article-title":"Effects of Metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome","volume":"338","author":"Nestler","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1097\/00000441-200512000-00012_bb0255","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1210\/jcem.85.8.6738","article-title":"Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome","volume":"85","author":"Pasquali","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200512000-00012_bb0260","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.fertnstert.2004.02.104","article-title":"A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and\/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study","volume":"82","author":"Hoeger","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1097\/00000441-200512000-00012_bb0265","first-page":"CD003053","article-title":"Insulin-sensitizing drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome","volume":"3","author":"Lord","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1097\/00000441-200512000-00012_bb0270","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0015-0282(01)01975-6","article-title":"Metformin directly inhibits androgen production in human thecal cells","volume":"76","author":"Attia","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1097\/00000441-200512000-00012_bb0275","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0015-0282(02)04925-7","article-title":"Metformin has direct effects on human ovarian steroidogenesis","volume":"79","author":"Mansfield","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1097\/00000441-200512000-00012_bb0280","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/bmj.327.7421.951","article-title":"Metformin in polycystic ovary syndrome: systematic review and meta-analysis","volume":"327","author":"Lord","year":"2003","journal-title":"Br Med J"},{"key":"10.1097\/00000441-200512000-00012_bb0285","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0015-0282(00)01666-6","article-title":"Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study","volume":"75","author":"Glueck","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1097\/00000441-200512000-00012_bb0290","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/humrep\/deh263","article-title":"Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy","volume":"19","author":"Glueck","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1097\/00000441-200512000-00012_bb0295","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0015-0282(01)03202-2","article-title":"Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome","volume":"77","author":"Glueck","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1097\/00000441-200512000-00012_bb0300","first-page":"1626","article-title":"Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial","volume":"86","author":"Azziz","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200512000-00012_bb0305","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0015-0282(02)04843-4","article-title":"Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovarian syndrome","volume":"79","author":"Ghazeeri","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1097\/00000441-200512000-00012_bb0310","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2004-1965","article-title":"Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with PCOS","volume":"90","author":"Ortega-Gonzalez","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200512000-00012_bb0315","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMra041001","article-title":"Thiazolidinediones","volume":"351","author":"Yki-Jarvinen","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1097\/00000441-200512000-00012_bb0320","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1210\/jc.2003-031205","article-title":"Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome","volume":"89","author":"Diamanti-Kandarakis","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200512000-00012_bb0325","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.metabol.2004.08.007","article-title":"Metformindiet benefits in women with polycystic ovary syndrome in the bottom and top quintiles for insulin resistance","volume":"54","author":"Goldenberg","year":"2005","journal-title":"Metab Clin Exp"},{"key":"10.1097\/00000441-200512000-00012_bb0330","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.fertnstert.2003.05.020","article-title":"Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome","volume":"81","author":"Genazzani","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1097\/00000441-200512000-00012_bb0335","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.fertnstert.2003.08.012","article-title":"Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin","volume":"81","author":"Maciel","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1097\/00000441-200512000-00012_bb0340","first-page":"143","article-title":"The use of metformin in overweight and lean infertile patients with polycystic ovarian syndrome: a randomized controlled trial","volume":"8","author":"Ramzy","year":"2003","journal-title":"Middle East Fertil Soc J"},{"key":"10.1097\/00000441-200512000-00012_bb0345","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/humrep\/deh207","article-title":"Polycystic ovary syndrome in adolescence-a therapeutic conundrum","volume":"19","author":"Homburg","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1097\/00000441-200512000-00012_bb0350","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1054-139X(01)00202-6","article-title":"Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome","volume":"29","author":"Glueck","year":"2001","journal-title":"J Adolesc Health"},{"key":"10.1097\/00000441-200512000-00012_bb0355","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1210\/jcem.86.8.7756","article-title":"Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism","volume":"86","author":"Ibanez","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200512000-00012_bb0360","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1210\/jc.2002-022002","article-title":"Low dose flutamidemetformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism","volume":"88","author":"Ibanez","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1097\/00000441-200512000-00012_bb0365","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0015-0282(16)35047-6","article-title":"Clinical and biochemical features of polycystic ovarian disease","volume":"6","author":"Goldzieher","year":"1963","journal-title":"Fertil Steril"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915328858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915328858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T02:39:52Z","timestamp":1554863992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915328858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":73,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0002962915328858"],"URL":"https:\/\/doi.org\/10.1097\/00000441-200512000-00012","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}